Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome.
Case ReportA 67-year-old woman was admitted with a refractory case of a burn on her left leg and hyperglycemia. She had been diagnosed with type 2 diabetes mellitus and hypertension seven years before her evaluation at our institution. On physical examination, she exhibited features typical of Cushing's syndrome, including a moon face, buffalo hump, truncal obesity and proximal muscle weakness. Her skin was atrophic, and she had purpura on her arm and legs. Her body mass index (BMI) was 34.3 kg/m 2 , her blood pressure was 173/116 mmHg and arterial blood gases showed hypoxia (pO2 50.2 mmHg, pCO2 46.8 mmHg, HCO3 -37.2 mmol/L and pH 7.5). The laboratory findings showed hypokalemia (K 3.1 mEq/L) and hyperglycemia (a fasting blood glucose level of 165 mg/mL, HbA1c 8.7%) ( Table 1). She had diabetes mellitus with simple retinopathy and early nephropathy. Her blood glucose levels were elevated in spite of treatment with a sulfonylurea and an α-glucosidase inhibitor (glibenclamide: 5 mg and acarbose: 100 mg). After admission, we started insulin injection therapy instead of oral administration. An electrocardiogram (ECG) showed RV5+SV1 35 mm, corresponding to left ventricle enlargement. The chest X-ray findings revealed cardiomegaly (cardiothoracic ratio (CTR): 66.1%) and were consistent with left cardiac failure. A transthoracic echocardiogram (ultrasound cardiography: UCG) revealed a dilated left ventricle (left ventricular end-diastolic diameter [LVDd]: 56 mm, left ventricular end-systolic diameter [LVDs]: 46 mm) and a left ventricle ejection fraction (LVEF) of 36% (Table 1) with an interventricular septum thickness (IVSt) of 13 mm, indicating mild hypertrophy. Cardiac catheterization confirmed dilated cardiomyopathy and severe ventricular dysfunction, with an LVEF of 18% and characteristic findings on a myocardial biopsy (Fig. 1). No coronary disease was detected. All serologies for myocarditis were negative. The level of B-type natriuretic peptide (BNP) was markedly elevated (1,746.1 pg/mL, as shown in Table 2). The 24-hour urinary free cortisol level was 249 μg/day (687.2 nmol, creatinine value: 4.2 mmol/24 hours). There was a loss of diurnal variation without suppression of the serum cortisol levels...